Comparative Metabolic Capabilities and Inhibitory Profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17

  title={Comparative Metabolic Capabilities and Inhibitory Profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17},
  author={Hongwu Shen and M. He and Houfu Liu and S. Wrighton and Li Wang and B. Guo and C. Li},
  journal={Drug Metabolism and Disposition},
  pages={1292 - 1300}
  • Hongwu Shen, M. He, +4 authors C. Li
  • Published 2007
  • Medicine, Biology
  • Drug Metabolism and Disposition
  • Polymorphisms in the cytochrome P450 2D6 (CYP2D6) gene are a major cause of pharmacokinetic variability in human. Although the poor metabolizer phenotype is known to be caused by two null alleles leading to absence of functional CYP2D6 protein, the large variability among individuals with functional alleles remains mostly unexplained. Thus, the goal of this study was to examine the intrinsic enzymatic differences that exist among the several active CYP2D6 allelic variants. The relative… CONTINUE READING
    138 Citations
    Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance
    • 337
    Functional and structural characterisation of common cytochrome P450 2D6 allelic variants—roles of Pro34 and Thr107 in catalysis and inhibition
    • 2
    • Highly Influenced
    Variation in the inhibitory potency of terbinafine among genetic variants of CYP2D6.
    • 1
    Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms In Vitro
    • 23
    Functional characterization of wild-type and 24 CYP2D6 allelic variants on gefitinib metabolism in vitro
    • 4
    • PDF
    Inter-individual variability of in vivo CYP2D6 activity in different genotypes.
    • 12
    • PDF


    Characterization of cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 activities toward model CYP2D6 substrates dextromethorphan, bufuralol, and debrisoquine.
    • 57
    • PDF
    Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates.
    • 87
    • PDF
    The decreased in vivo clearance of CYP2D6 substrates by CYP2D6*10 might be caused not only by the low-expression but also by low affinity of CYP2D6.
    • 80
    • Highly Influential
    A combination of mutations in the CYP2D6*17 (CYP2D6Z) allele causes alterations in enzyme function.
    • 143
    Substrate specific metabolism by polymorphic cytochrome P450 2D6 alleles.
    • 49
    Effect of antipsychotic drugs on human liver cytochrome P-450 (CYP) isoforms in vitro: preferential inhibition of CYP2D6.
    • 137
    • Highly Influential
    • PDF
    (R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes.
    • 112
    • PDF
    Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.
    • 1,032